Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Siegfried | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Siegfried

1H revenues up 22%

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Siegfried
 
1H Revenues: CHF 200.7 million (+22%)

1H Earnings: CHF 20.1 million (+7%)

Comments: Sales of active pharmaceutical ingredients grew by 3%, driven by API synthesis, which grew 28% in the first half. Finished dosage forms grew 81%, mainly from the acquisition of Hameln Pharma at the end of 2014. The new production facility in Nantong was inaugurated in the first half and the company completed the acquisition of several segments of BASF’s pharmaceutical supply business.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics